AeroRx Therapeutics Reports Positive Phase 2a Results for Inhaled AERO-007 in COPD as First Nebulized LABA/LAMA Combination Candidate AeroRx Therapeutics has reported positive Phase 2a clinical data for AERO-007, an investigational nebulized fixed-dose combination therapy being developed for the treatment…
iECURE Reports Durable Response With ECUR-506 in OTC-HOPE Trial and Reduced Hyperammonemic Events in Initial Cohort iECURE has reported encouraging preliminary clinical data from the low-dose cohort of its ongoing OTC-HOPE trial evaluating ECUR-506, an investigational in vivo targeted gene…
Amylyx Publishes Phase 2 HELIOS Trial Results Showing Continued Benefits of AMX0035 in Wolfram Syndrome Amylyx Pharmaceuticals announced that detailed Week 24 and Week 48 findings from the Phase 2 HELIOS clinical trial evaluating AMX0035 in adults living with Wolfram…
Kraken Regen Launches Advanced Collagen Platform Technology to Support Regenerative Medicine Research Kraken Regen has announced the launch of its new Collagen Platform Technology, introducing a high-purity collagen biomaterial engineered to support next-generation research in regenerative medicine, 3D bioprinting, and…
Worldwide Clinical Trials Expands Leadership Team to Enhance Global Reach and Therapeutic Expertise Worldwide Clinical Trials, a global contract research organization (CRO) focused on delivering specialized clinical development services for the biopharmaceutical and medical device industries, has announced a series…
OrganaBio Acquires Excellos Assets to Expand Nationwide Cell Therapy Testing, Development and Manufacturing Capabilities OrganaBio, a U.S.-based manufacturer of GMP-compliant cellular products and provider of cell isolation and cryopreservation services, has announced the acquisition of substantially all operating assets of…
Aptar Pharma Advances FDA-Supported Research on Next-Generation Propellants for Metered-Dose Inhalers Aptar Pharma, a global company specializing in drug delivery systems, dosing technologies, protection solutions, and pharmaceutical services, has announced continued progress in its multi-year research collaboration with the U.S.…
Northwell’s Feinstein Institutes Researcher Alex C. Spyropoulos Receives Prestigious Fulbright U.S. Scholar Recognition Alex C. Spyropoulos, an internationally recognized authority in thrombosis and blood clotting disorders, has been awarded a prestigious Fulbright U.S. Scholar distinction for the 2026–2027 academic year.…
SCIEX Enhances Workflow Efficiency Through Software Innovations Backed by Six Strategic Industry Collaborations SCIEX, a subsidiary of Danaher Corporation and a recognized leader in analytical technologies, is advancing its vision of a fully integrated digital ecosystem for modern laboratories through…
Spruce Biosciences Bolsters Commercial Leadership with Appointment of Brian Walls as VP, Market Access, and Darren Johnson as VP, Commercial Operations Spruce Biosciences, a late-stage biopharmaceutical company focused on developing and commercializing therapies for neurological disorders with significant unmet medical…
OpRegen® 3-Year Data in Geographic Atrophy Patients Showcased at Foundation Fighting Blindness Retinal Innovation Summit 2026 Lineage Cell Therapeutics (NYSE American and TASE: LCTX), a clinical-stage biotechnology company focused on developing off-the-shelf allogeneic cell therapies for serious medical conditions, has…
Insulet Launches EVOLVE Pivotal Trial to Accelerate Development of a Fully Closed-Loop Insulin Delivery System for Type 2 Diabetes Insulet Corporation, a global pioneer in tubeless insulin pump technology through its Omnipod® platform, has taken a significant step forward in…